Infections affecting nearly three-quarters of people with myeloma taking part in clinical testing for the now-approved treatment Lynozyfic…
Articles by Marisa Horak, MS
The U.S. Food and Drug Administration’s (FDA) recent approval of Takeda‘s injection therapy Mimrylo (rusfertide) to treat excessive blood…
Adding the experimental anti-CD38 therapy felzartamab reduced the risk of disease progression among people with hard-to-treat myeloma in a…
A large U.S. clinical trial is now underway to test a newly approved pancreatic cancer drug in combination with…
For people with myeloma who undergo a stem cell transplant using their own cells, the key determinant of the…
An early-stage U.S. clinical trial testing the infusion treatment liraltagene autoleucel (lira-cel) for ovarian cancer is now seeking women…
A short course of ultra-low-dose radiation may relieve pain for many people with multiple myeloma who have uncomplicated bone…
New data from a long-term clinical trial show 10 of 20 people with hard-to-treat multiple myeloma are alive and…
An arm of the European Medicines Agency (EMA) has recommended expanding the European approval of Johnson & Johnson‘s Tecvayli…
The experimental immunotherapy IGV-001 may improve survival outcomes in certain people with an aggressive form of glioma called glioblastoma…